Tiansheng Pharmaceutical Group Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 601.84 million compared to CNY 900.11 million a year ago. Revenue was CNY 601.84 million compared to CNY 900.11 million a year ago. Net loss was CNY 67.84 million compared to CNY 119.3 million a year ago. Basic loss per share from continuing operations was CNY 0.2133 compared to CNY 0.3752 a year ago. Diluted loss per share from continuing operations was CNY 0.2133 compared to CNY 0.3752 a year ago.